Improving Asthma Care: An Update for Managed CareAchieving Optimal Outcomes (Enduring Webinar)
Aidan A. Long, MD
Clinical Director, Allergy and Immunology
Massachusetts General Hospital
Aidan A. Long, MD has disclosed expert testimony for GlaxoSmithKline.
The planning staff from the University of Cincinnati, The American Journal of Managed Care, and the Pharmacy Times Office of Continuing Professional Education have no relevant financial relationships to disclose.
This activity is supported by an educational grant from Merck & Co, Inc.
Asthma still exacts a severe national burden through patient morbidity and mortality, rising healthcare costs, and employee absenteeism. There is a need to improve the management of asthma to improve outcomes and alleviate the burden on the patient and healthcare system.
This CE/CME activity will provide managed care healthcare professionals an overview of the unmet needs in asthma, discuss the pharmacoeconomic implications of therapy as they relate to clinical outcomes, and identify strategies that can help improve patients and providers achieve asthma control.
Medical directors, pharmacy directors, and other managed care professionals who oversee the care of patients with asthma.
Upon completion of this educational activity, participants should be able to:
The contents of this CE activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.
Type of Activity: Application-based.
Length of Webinar: One hour including pre-recorded question-and-answer session.
Original Release Date: May 25, 2011
Expiration Date: May 25,
This CE lesson is contained in the following video/webinar:
This CE lesson is contained in the following PDF slides:
Requirements to view this webinar:
The webinar requires a media player capable of viewing files in the WMV or MP4 video format, and/or Adobe Acrobat Reader for viewing the pdf.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the University of Cincinnati. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pharmacy Times Office of Continuing Professional Education
is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 1 contact hour (0.1 CEU) under the ACPE universal program number 0290-9999-11-032-H01-P. The program is available for CE credit through May 25, 2012.
The information in this presentation is intended for educational use and to stimulate professional discussion among colleagues. It should not be construed as legal advice. There is no way such a brief discussion of an issue or topic for educational or discussion purposes can adequately and fully address the multifaceted and often complex issues that arise in the course of professional practice. Moreover, statutes, regulations and court interpretations of the law can vary from jurisdiction to jurisdiction. It is always the best advice for a pharmacist to seek counsel from an attorney who can become thoroughly familiar with the intricacies of a specific situation and render advice in accordance with the full information.
How to Receive Credit:
After viewing the activity “Improving Asthma Care: An Update for Managed Care - Emerging Therapeutic Options for Asthma,” complete the program evaluation and select the 1 best answer to each of the posttest questions.
A statement of continuing education hours will be provided to those physicians and pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher.